Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
19
Number of overlapping holdings
5.9%
% of FHLC's 349 holdings also in MEDX
63.3%
% of MEDX's 30 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 16.8% | 11.3% |
|
ABBVIE INC | 6.1% | 9.6% | 6.1% |
|
JOHNSON & JOHNSON | 6.4% | 5.1% | 5.1% |
|
MERCK & CO. INC. | 3.8% | 3.6% | 3.6% |
|
AMGEN INC | 2.8% | 6.3% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 7.3% |
|
ABBOTT LABORATORIES | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
GILEAD SCIENCES INC | 2.3% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
|
DANAHER CORP | 2.2% |
|
STRYKER CORP | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
 |
MEDTRONIC PLC | 1.9% |
FHLC Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -6.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
|
ELI LILLY & CO | -5.5% |
|
ALKERMES PLC | -4.6% |
|
BRISTOL-MYERS SQUIBB CO | -4.5% |
|
ALNYLAM PHARMACEUTICALS INC | -4.2% |
|
ABBVIE INC | -3.5% |
|
AMGEN INC | -3.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.3% |